Osteoporosis Clinic, Department of Endocrinology and Internal Medicine, Aarhus University Hospital THG, Tage Hansens Gade 2, Aarhus, Denmark.
Eur J Endocrinol. 2012 Jun;166(6):1093-100. doi: 10.1530/EJE-12-0032. Epub 2012 Apr 3.
To study the prevalence of renal stones and nephrocalcinosis in patients with primary hyperparathyroidism (PHPT) and to appraise biochemical variables as risk factors for developing renal calcifications.
Cross-sectional.
All patients (n=177) undergoing diagnostic evaluation and surgery for PHPT at Aarhus University Hospital between 2007 and 2009. All patients underwent routine spiral CT scans of the abdomen to determine the presence or absence of renal calcifications.
A total of 45 patients (25.4%, 95% confidence intervals: 19.0-31.4%) had renal stones (15.3%) and/or renal calcifications (10.2%) on the CT scans. Compared with those without calcification (n=132), the group with calcification had a significantly lower plasma creatinine level (67.0±25.1 vs 74.6±17.5 μmol/l, 2P=0.03). Moreover, CaE was higher in PHPT patients with renal calcification than in PHPT patients without (0.91±0.28 vs 0.74±0.40 mmol/mmol, 2P=0.02). The other measured or derived biochemical variables were similar in the two groups. No biochemical variable was predictive for renal calcifications in a multiple regression analysis.
We found a high prevalence of renal calcifications among PHPT patients but no deterioration of renal function. The occurrence of calcifications was related to low plasma creatinine and a high urine calcium/creatinine ratio. However, biochemical markers in general were poor predictors for the risk of renal stones or nephrocalcinosis indicating that routine image diagnostics may be needed for the identification of these complications in order to establish indication for surgery and ensure proper treatment.
研究原发性甲状旁腺功能亢进症(PHPT)患者肾结石和肾钙质沉着症的患病率,并评估生化变量作为发生肾钙化的危险因素。
横断面研究。
所有在 2007 年至 2009 年期间在奥胡斯大学医院接受 PHPT 诊断评估和手术的患者(n=177)。所有患者均接受常规腹部螺旋 CT 扫描,以确定是否存在肾钙化。
共有 45 例患者(25.4%,95%置信区间:19.0-31.4%)在 CT 扫描中出现肾结石(15.3%)和/或肾钙化(10.2%)。与无钙化组(n=132)相比,钙化组的血浆肌酐水平明显较低(67.0±25.1 vs 74.6±17.5 μmol/l,2P=0.03)。此外,PHPT 患者中伴有肾钙化的钙磷乘积(CaE)高于无肾钙化的患者(0.91±0.28 vs 0.74±0.40 mmol/mmol,2P=0.02)。两组的其他测量或推导的生化变量相似。在多元回归分析中,没有生化变量可以预测肾钙化。
我们发现 PHPT 患者中肾钙化的患病率很高,但肾功能没有恶化。钙化的发生与低血浆肌酐和高尿钙/肌酐比值有关。然而,生化标志物总体上对肾结石或肾钙质沉着症的风险预测能力较差,表明为了确定这些并发症的存在并确定手术指征,需要进行常规影像诊断,以确保适当的治疗。